Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zorblisa in Epidermolysis Bullosa
NCT02014376Phase 2Completed
- Sponsor
- Scioderm
- Start
- Jan 2014
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allantoin in epidermolysis bullosa (EB), sponsored by Scioderm. Started Jan 2014; status: completed.
02
Drugs
allantoin
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT02014376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014376.